Drug
US Ocrevus
US Ocrevus: highest development phase Phase 1, developed by Polpharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Polpharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| US-Ocrevus NCT07606521 | Phase 1 | Multiple Sclerosis |
Latest
No recent events.
Follow US Ocrevus on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.